Bonus & Incentive Agreements in the Pharmaceuticals Industry

2,249 Contracts & Agreements

Browse by Company

60 DEGREES PHARMACEUTICALS, INC. (2 contracts)
Acasti Pharma Inc. (1)
ACELRX PHARMACEUTICALS INC (18)
Acer Therapeutics Inc. (10)
ACHILLION PHARMACEUTICALS INC (7)
Aclaris Therapeutics, Inc. (5)
Acreage Holdings, Inc. (4)
ACURA PHARMACEUTICALS, INC (2)
Adamis Pharmaceuticals Corp (14)
ADIAL PHARMACEUTICALS, INC. (7)
Aegerion Pharmaceuticals, Inc. (6)
AEON Biopharma, Inc. (6)
AERIE PHARMACEUTICALS INC (6)
Aerpio Pharmaceuticals, Inc. (10)
AGILE THERAPEUTICS INC (5)
Akers Biosciences, Inc. (8)
Akorn (6)
ALDER BIOPHARMACEUTICALS INC (9)
Alexza Pharmaceuticals Inc. (9)
ALGORX PHARMACEUTICALS INC (1)
ALIMERA SCIENCES INC (17)
Allergan, plc (9)
ALSERES PHARMACEUTICALS INC (2)
Altus Pharmaceuticals Inc. (3)
Amag Pharmaceuticals (20)
Amneal Pharmaceuticals, Inc. (6)
Amphastar Pharma (3)
Ampio Pharmaceuticals, Inc. (4)
AMYLIN PHARMACEUTICALS INC (7)
Amylyx Pharmaceuticals, Inc. (3)
AN2 Therapeutics, Inc. (5)
Anacor Pharmaceuticals, Inc. (9)
Anebulo Pharmaceuticals, Inc. (2)
Angion Biomedica Corp. (11)
ANI Pharma Inc (21)
Anthera Pharmaceuticals Inc (7)
APP Pharmaceuticals, Inc. (1)
APRICUS BIOSCIENCES, INC. (4)
Aquestive Therapeutics, Inc. (5)
Aralez Pharmaceuticals Inc. (11)
ARIAD PHARMACEUTICALS INC (11)
Arog Pharmaceuticals, Inc. (1)
ARTELO BIOSCIENCES, INC. (2)
ARVINAS, INC. (7)
Assertio Holdings, Inc. (4)
Assertio Therapeutics, Inc (22)
ATAI Life Sciences B.V. (6)
Atea Pharmaceuticals, Inc. (4)
Athira Pharma, Inc. (8)
Auspex Pharmaceuticals, Inc. (6)
AUXILIUM PHARMACEUTICALS INC (5)
AVADEL PHARMACEUTICALS PLC (3)
AVALON PHARMACEUTICALS INC (4)
AVANIR PHARMACEUTICALS, INC. (7)
AVENUE THERAPEUTICS, INC. (1)
Axsome Therapeutics, Inc. (3)
AYTU BIOSCIENCE, INC (1)
Bakhu Holdings, Corp. (1)
Baudax Bio, Inc. (2)
Bausch Health Companies Inc. (27)
BENTLEY PHARMACEUTICALS INC (5)
Bespoke Extracts, Inc. (1)
BIODELIVERY SCIENCES INTERNATIONAL INC (14)
Biofrontera Inc. (5)
Biohaven Ltd. (1)
BioPharmX Corp (4)
Blue Water Acquisition Corp. (2)
Braeburn Pharmaceuticals, Inc. (1)
Bristol-Myers Squibb (106)
CADENCE PHARMACEUTICALS INC (10)
Cancer Prevention Pharmaceuticals, Inc. (6)
Cannabics Pharmaceuticals Inc. (1)
Canopy Growth Corp (8)
Cara Therapeutics, Inc. (4)
CARDAX, INC. (1)
CASSAVA SCIENCES INC (10)
Catalent Inc (38)
Celator Pharmaceuticals Inc (1)
CELGENE CORP (15)
CERAGENIX PHARMACEUTICALS, INC. (1)
Cerecor Inc. (6)
CHIASMA, INC (2)
CHINA PHARMA HOLDINGS, INC. (3)
CinCor Pharma, Inc. (1)
Cingulate Inc. (3)
Citius Pharmaceuticals, Inc. (3)
Clearside Biomedical, Inc. (7)
Clever Leaves Holdings Inc. (6)
CLS Holdings USA, Inc. (1)
Cocrystal Pharma, Inc. (1)
COGNITION THERAPEUTICS INC (6)
COLLEGIUM PHARMACEUTICAL, INC (13)
CoLucid Pharmaceuticals, Inc. (7)
Columbia Care Inc. (1)
Context Therapeutics Inc. (3)
Corcept Therapeutics Incorporated (6)
CorMedix Inc. (6)
COSMO VENTURES INC (1)
CPEX Pharmaceuticals, Inc. (1)
Cronos Group Inc. (3)
CUBIST PHARMACEUTICALS INC (29)
CUMBERLAND PHARMACEUTICALS INC (10)
Cure Pharmaceutical Holding Corp. (4)
CymaBay Therapeutics, Inc. (3)
Cyteir Therapeutics, Inc. (9)
Dermata Therapeutics, Inc. (5)
DiCE MOLECULES HOLDINGS, LLC (2)
Dova Pharmaceuticals Inc. (4)
EASTON PHARMACEUTICALS INC. (1)
Edgewise Therapeutics, Inc. (3)
Egalet Corp (12)
Elanco Animal Health Inc (9)
Elixir Pharmaceuticals, Inc. (5)
Eloxx Pharmaceuticals, Inc. (8)
ENCYSIVE PHARMACEUTICALS INC (1)
Endo International plc (39)
Endo Pharmaceuticals Solutions Inc. (4)
EPIX Pharmaceuticals, Inc. (6)
Eton Pharmaceuticals, Inc. (6)
Evofem Biosciences, Inc. (13)
Evoke Pharma Inc (5)
Evolus, Inc. (7)
Exactus, Inc. (7)
EYEGATE PHARMACEUTICALS INC (8)
EYENOVIA, INC. (6)
EyePoint Pharmaceuticals, Inc. (24)
EYETECH PHARMACEUTICALS INC (2)
Foamix Pharmaceuticals Ltd. (3)
Fulcrum Therapeutics, Inc. (10)
GB SCIENCES INC (1)
GENAISSANCE PHARMACEUTICALS INC (2)
GRAYBUG VISION, INC. (3)
Green Thumb Industries Inc. (2)
GUILFORD PHARMACEUTICALS INC (2)
GW PHARMACEUTICALS PLC (2)
Harmony Biosciences Holdings, Inc. (7)
HARROW HEALTH, INC. (11)
Horizon Pharma plc (13)
Hoth Therapeutics, Inc. (1)
IDENIX PHARMACEUTICALS INC (8)
Ikena Oncology, Inc. (2)
IMARA Inc. (11)
INNOVATE BIOPHARMACEUTICALS, INC. (12)
Innoviva, Inc. (33)
INSPIRE PHARMACEUTICALS INC (5)
Intersect ENT, Inc. (10)
Intra-Cellular Therapies, Inc. (14)
ISTA PHARMACEUTICALS INC (3)
Iterum Therapeutics plc (11)
Jaguar Health, Inc. (5)
JAVELIN PHARMACEUTICALS, INC (2)
Jazz Pharmaceuticals plc (64)
Johnson & Johnson (8)
JUNIPER PHARMACEUTICALS INC (9)
Jushi Holdings Inc. (2)
Kala Pharmaceuticals, Inc. (12)
Kaleido Biosciences, Inc. (3)
Kannalife Inc (2)
Kaya Holdings, Inc. (1)
KEMPHARM, INC (4)
KING PHARMACEUTICALS INC (19)
KOLLTAN PHARMACEUTICALS INC (3)
KOS PHARMACEUTICALS INC (1)
Landos Biopharma, Inc. (1)
Lannett Company, Inc. (1)
Lexaria Bioscience Corp. (1)
Lilly (Eli) & Co. (23)
LIPELLA PHARMACEUTICALS INC (7)
Lipocine Inc. (5)
Liquidia Corp (3)
Liquidia Technologies Inc (1)
Longboard Pharmaceuticals, Inc. (6)
Lowell Farms Inc. (1)
Lumena Pharmaceuticals, Inc. (1)
Lyra Therapeutics, Inc. (5)
Mallinckrodt (23)
MAP Pharmaceuticals, Inc. (2)
Marijuana Co of America, Inc. (1)
MARINUS PHARMACEUTICALS INC (16)
Medicine Man Technologies, Inc. (6)
MedMen Enterprises, Inc. (1)
Melt Pharmaceuticals, Inc. (5)
MEMORY PHARMACEUTICALS CORP (1)
Menlo Therapeutics Inc. (12)
Merck (58)
MiddleBrook Pharmaceuticals, Inc. (1)
Milestone Pharmaceuticals Inc. (6)
MILLENNIUM PHARMACEUTICALS INC (2)
Mind Medicine (MindMed) Inc. (2)
MIRA PHARMACEUTICALS, INC. (2)
Molecular Insight Pharmaceuticals, Inc. (2)
Mylan N.V. (17)
MYnd Analytics, Inc. (3)
MyoKardia Inc (4)
Nabriva Therapeutics plc (13)
NEKTAR THERAPEUTICS (23)
Neos Therapeutics, Inc. (2)
Neuralstem, Inc. (11)
NEW RIVER PHARMACEUTICALS INC (1)
NEXIEN BIOPHARMA, INC. (2)
NGM BIOPHARMACEUTICALS INC (5)
NovaBay Pharmaceuticals, Inc. (8)
Novan, Inc. (7)
NPS PHARMACEUTICALS INC (7)
NUCRYST Pharmaceuticals Corp. (4)
OCULAR THERAPEUTIX, INC (10)
OMEROS CORP (4)
Omthera Pharmaceuticals, Inc. (2)
OncoMed Pharmaceuticals Inc (6)
Onconova Therapeutics, Inc. (4)
One World Pharma, Inc. (3)
ONYX PHARMACEUTICALS INC (12)
OPIANT PHARMACEUTICALS, INC. (6)
OPTIMER PHARMACEUTICALS INC (5)
OptiNose, Inc. (7)
ORAMED PHARMACEUTICALS INC. (4)
Organon & Co. (3)
OSCIENT PHARMACEUTICALS CORP (2)
OSI PHARMACEUTICALS INC (6)
Osmotica Pharmaceuticals plc (9)
OTONOMY, INC. (4)
Pacira Pharmaceuticals, Inc. (12)
Panacea Acquisition Corp (6)
PANACOS PHARMACEUTICALS, INC. (4)
Paratek Pharmaceuticals, Inc. (13)
PaxMedica, Inc. (5)
PEAK PHARMACEUTICALS, INC. (1)
PENWEST PHARMACEUTICALS CO (7)
Perrigo (40)
PetLife Pharmaceuticals, Inc. (1)
Petros Pharmaceuticals, Inc. (3)
Pfizer (9)
Phathom Pharmaceuticals, Inc. (10)
Phibro Animal Health Corporation (3)
PLIANT THERAPEUTICS, INC. (3)
PLx Pharma Inc. (5)
PONIARD PHARMACEUTICALS, INC. (11)
PRAECIS PHARMACEUTICALS INC (1)
PREDIX PHARMACEUTICALS HOLDINGS INC (3)
Prestige Brands Holdings Inc (4)
Processa Pharmaceuticals, Inc. (2)
ProPhase Labs, Inc. (3)
Provention Bio, Inc. (3)
Pulmatrix, Inc. (6)
QUANTA INC (1)
QUARK PHARMACEUTICALS INC (3)
QUATRX PHARMACEUTICALS CO (1)
QUESTCOR PHARMACEUTICALS INC (3)
Ra Pharmaceuticals, Inc. (2)
RADIENT PHARMACEUTICALS Corp (1)
Rain Therapeutics Inc. (9)
Rani Therapeutics Holdings, Inc. (3)
REATA PHARMACEUTICALS INC (3)
Recro Pharma, Inc. (9)
Reliant Pharmaceuticals, Inc. (7)
RELMADA THERAPEUTICS, INC. (11)
RespireRx Pharmaceuticals Inc. (16)
resTORbio, Inc. (19)
Revance Therapeutics, Inc. (21)
Rib-X Pharmaceuticals, Inc. (10)
ROCK CREEK PHARMACEUTICALS, INC. (7)
Roivant Sciences Ltd. (9)
Royalty Pharma plc (2)
Sagent Pharmaceuticals, Inc. (5)
SALIX PHARMACEUTICALS LTD (1)
SANCILIO PHARMACEUTICALS COMPANY, INC. (2)
Satsuma Pharmaceuticals, Inc. (7)
SAVIENT PHARMACEUTICALS INC (4)
SCICLONE PHARMACEUTICALS INC (13)
Scopus BioPharma Inc. (2)
scPharmaceuticals Inc. (3)
SCYNEXIS INC (4)
SenesTech, Inc. (5)
Shuttle Pharmaceuticals, Inc. (1)
Sienna Biopharmaceuticals, Inc. (11)
SIGA TECHNOLOGIES INC (1)
Strongbridge Biopharma plc (1)
Sucampo Pharmaceuticals, Inc. (9)
Supernus Pharmaceuticals, Inc. (9)
SYNERGY PHARMACEUTICALS, INC. (1)
TAPESTRY PHARMACEUTICALS, INC (3)
Targeted Medical Pharma, Inc. (5)
Tarsus Pharmaceuticals, Inc. (2)
Tenzing Acquisition Corp. (4)
Terns Pharmaceuticals, Inc. (8)
Terra Tech Corp. (7)
TETRALOGIC PHARMACEUTICALS CORP (4)
TETRAPHASE PHARMACEUTICALS INC (7)
TEVA PHARMACEUTICAL INDUSTRIES LTD (19)
TFF Pharmaceuticals, Inc. (1)
THAR PHARMACEUTICALS INC (2)
The Medicines Company (16)
TherapeuticsMD, Inc. (2)
Theravance Biopharma, Inc. (9)
Theseus Pharmaceuticals, Inc. (2)
Tilray, Inc. (4)
TILT Holdings Inc. (4)
TITAN PHARMACEUTICALS INC (7)
Trevi Therapeutics, Inc. (4)
Tricida, Inc. (3)
Trulieve Cannabis Corp. (1)
Upjohn Inc (8)
Urigen Pharmaceuticals, Inc. (2)
Urovant Sciences Ltd. (5)
VALEANT PHARMACEUTICALS INTERNATIONAL (2)
Valera Pharmaceuticals Inc (2)
Vallon Pharmaceuticals, Inc. (8)
Ventyx Biosciences, Inc. (4)
Verano Holdings Corp. (1)
Verona Pharma plc (1)
Verrica Pharmaceuticals Inc. (4)
Viamet Pharmaceuticals Holdings LLC (3)
VION PHARMACEUTICALS INC (2)
VioQuest Pharmaceuticals, Inc. (2)
Virpax Pharmaceuticals, Inc. (6)
Vitae Pharmaceuticals, Inc (4)
Vitality Biopharma, Inc. (4)
VIVUS INC (3)
Wave Life Sciences Ltd. (16)
Winston Pharmaceuticals, Inc. (1)
XANODYNE PHARMACEUTICALS INC (4)
XERIS PHARMACEUTICALS INC (3)
Zoetis (9)
ZOGENIX, INC. (11)
Zynerba Pharmaceuticals, Inc. (12)

Recent Contracts

Form of Aadi Bioscience, Inc. 2023 Inducement Equity Incentive Plan Stock Option Agreement (Aerpio Pharmaceuticals, Inc., Filed With SEC on October 2, 2023)
Aadi Bioscience, Inc. 2023 Inducement Equity Incentive Plan (Aerpio Pharmaceuticals, Inc., Filed With SEC on October 2, 2023)
Form of Restricted Stock Unit Award Agreement under the Aadi Bioscience, Inc. 2021 Equity Incentive Plan (Aerpio Pharmaceuticals, Inc., Filed With SEC on October 2, 2023)
First Amendment to Amended and Restated Petros Pharmaceuticals, Inc. 2020 Omnibus Incentive Compensation Plan (Petros Pharmaceuticals, Inc., Filed With SEC on September 15, 2023)
Performance Guaranty, dated as of August 30, 2023 (Mallinckrodt, Filed With SEC on September 6, 2023)
Originator Performance Guaranty, dated as of August 30, 2023 (Mallinckrodt, Filed With SEC on September 6, 2023)
Executive Long-Term Incentive Agreement dated July 5, 2023 by and between Phibro Animal Health Corporation and Larry L. Miller (Phibro Animal Health Corporation, Filed With SEC on August 30, 2023)
Form of Restricted Stock Award Agreement for Non-Employee Directors under Zynerba Pharmaceuticals, Inc. 2023 Stock Option and Incentive Plan (Zynerba Pharmaceuticals, Inc., Filed With SEC on August 14, 2023)
Form of Restricted Stock Award Agreement under Zynerba Pharmaceuticals, Inc. 2023 Stock Option and Incentive Plan (Zynerba Pharmaceuticals, Inc., Filed With SEC on August 14, 2023)
Form of Non-Qualified Stock Option Agreement for Non-Employee Directors under Zynerba Pharmaceuticals, Inc. 2023 Stock Option and Incentive Plan (Zynerba Pharmaceuticals, Inc., Filed With SEC on August 14, 2023)
Form of Non-Qualified Stock Option Agreement for Company Employees under Zynerba Pharmaceuticals, Inc. 2023 Stock Option and Incentive Plan (Zynerba Pharmaceuticals, Inc., Filed With SEC on August 14, 2023)
Form of Incentive Stock Option Agreement under Zynerba Pharmaceuticals, Inc. 2023 Stock Option and Incentive Plan (Zynerba Pharmaceuticals, Inc., Filed With SEC on August 14, 2023)
Zynerba Pharmaceuticals, Inc. 2023 Stock Option and Incentive Plan (Zynerba Pharmaceuticals, Inc., Filed With SEC on August 14, 2023)
Amendment Number 3 to the Amended and Restated 2007 Long-Term Incentive Compensation Plan, incorporated herein by reference to Appendix A of the Companys Schedule 14A (File No.:... (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on August 11, 2023)
Indus Holdings, Inc 2019 Stock and Incentive Plan (Lowell Farms Inc., Filed With SEC on August 10, 2023)
Palisade Bio, Inc. 2021 Inducement Incentive Plan, as Amended August 7, 2023 (Neuralstem, Inc., Filed With SEC on August 10, 2023)
Form of Restricted Stock Option and Performance Share Unit Award Agreement (Medicine Man Technologies, Inc., Filed With SEC on August 10, 2023)
Description of Medicine Man Technologies, Inc. 2023 Long-Term Incentive Plan (Medicine Man Technologies, Inc., Filed With SEC on August 10, 2023)
Nektar Therapeutics Amended and Restated 2017 Performance Incentive Plan, as amended (NEKTAR THERAPEUTICS, Filed With SEC on August 9, 2023)
Amneal Pharmaceuticals, Inc. 2018 Incentive Award Plan, as amended and restated (Amneal Pharmaceuticals, Inc., Filed With SEC on August 8, 2023)
2021 Stock Incentive Plan, as amended (OCULAR THERAPEUTIX, INC, Filed With SEC on August 7, 2023)
Wave Life Sciences Ltd. 2021 Equity Incentive Plan, as amended (Wave Life Sciences Ltd., Filed With SEC on August 7, 2023)
Form of Incentive Stock Option Agreement under Amended and Restated 2017 Equity Incentive Plan (Kala Pharmaceuticals, Inc., Filed With SEC on August 4, 2023)
Form of Non-Qualified Option Agreement under Amended and Restated 2017 Equity Incentive Plan (Kala Pharmaceuticals, Inc., Filed With SEC on August 4, 2023)
Form of Non-Employee Director Restricted Stock Unit Award under Amended and Restated 2017 Equity Incentive Plan (Kala Pharmaceuticals, Inc., Filed With SEC on August 4, 2023)
Form of Non-Employee Director Deferred Restricted Stock Unit Award under Amended and Restated 2017 Equity Incentive Plan (Kala Pharmaceuticals, Inc., Filed With SEC on August 4, 2023)
Form of Employee Restricted Stock Unit Award under Amended and Restated 2017 Equity Incentive Plan (Kala Pharmaceuticals, Inc., Filed With SEC on August 4, 2023)
Amendment to the Avadel Pharmaceuticals plc 2020 Omnibus Incentive Compensation Plan (AVADEL PHARMACEUTICALS PLC, Filed With SEC on August 3, 2023)
Cassava Sciences, Inc. 2020 Cash Incentive Bonus Plan (As Amended March 16, 2023) (CASSAVA SCIENCES INC, Filed With SEC on August 3, 2023)
Second Amendment to the Dermata Therapeutics, Inc. 2021 Omnibus Equity Incentive Plan (Dermata Therapeutics, Inc., Filed With SEC on August 3, 2023)
Form of 2012 Incentive Award Plan Restricted Stock Award Grant Notice and Agreement (Corcept Therapeutics Incorporated, Filed With SEC on August 2, 2023)
Form of 2012 Incentive Award Plan Restricted Stock Unit Grant Notice and Agreement (Corcept Therapeutics Incorporated, Filed With SEC on August 2, 2023)
Alimera Sciences, Inc. 2023 Equity Incentive Plan and forms of award agreements thereunder (ALIMERA SCIENCES INC, Filed With SEC on August 2, 2023)
Ampio Pharmaceuticals, Inc. 2023 Stock and Incentive Plan (Ampio Pharmaceuticals, Inc., Filed With SEC on August 1, 2023)
Form of Stock Option Award under 2022 Omnibus Incentive Plan (MIRA PHARMACEUTICALS, INC., Filed With SEC on June 29, 2023)
2022 Omnibus Incentive Plan, as amended and restated (MIRA PHARMACEUTICALS, INC., Filed With SEC on June 29, 2023)
Form of Stock Option Grant Notice under the Roivant Sciences Ltd. Amended and Restated 2015 Equity Incentive Plan (Roivant Sciences Ltd., Filed With SEC on June 28, 2023)
Form of Restricted Stock Unit Award Grant Notice under the Roivant Sciences Ltd. Amended and Restated 2015 Equity Incentive Plan (Roivant Sciences Ltd., Filed With SEC on June 28, 2023)
Form of Performance Option Grant Notice under the Roivant Sciences Ltd. Amended and Restated 2015 Equity Incentive Plan (Roivant Sciences Ltd., Filed With SEC on June 28, 2023)
Form of Capped Value Appreciation Right Award Grant Notice under the Roivant Sciences Ltd. Amended and Restated 2015 Equity Incentive Plan (Roivant Sciences Ltd., Filed With SEC on June 28, 2023)